MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617063796 A) filed by Kumquat Biosciences Inc. on May 20, 2026, for Combinations Of Sos-1 Inhibitors With Osimertinib And/Or Met Inhibitors To Treat Cancer.
Inventors include Liu, Yi; Janes, Matthew R.; and Hansen, Rasmus.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present disclosure provides compounds and pharmaceutically acceptable salt thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins when used in combination with one or more other therapeutic agents.
Disclaimer: Curated by HT Syndication.
